hVIVO plc (LON:HVO - Get Free Report) was up 9.5% on Friday . The stock traded as high as GBX 15.75 ($0.20) and last traded at GBX 15.61 ($0.20). Approximately 1,709,755 shares traded hands during trading, a decline of 48% from the average daily volume of 3,283,339 shares. The stock had previously closed at GBX 14.25 ($0.18).
hVIVO Stock Performance
The company has a market capitalization of £103.31 million, a price-to-earnings ratio of 6.02 and a beta of 0.97. The company has a debt-to-equity ratio of 33.86, a quick ratio of 1.16 and a current ratio of 1.61. The firm's 50 day simple moving average is GBX 16.22 and its 200-day simple moving average is GBX 20.93.
Insider Buying and Selling at hVIVO
In other news, insider Yamin Mo' Khan sold 3,062,246 shares of the firm's stock in a transaction on Thursday, March 6th. The shares were sold at an average price of GBX 17 ($0.22), for a total transaction of £520,581.82 ($665,195.27). Company insiders own 14.03% of the company's stock.
About hVIVO
(
Get Free Report)
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Featured Articles
Before you consider hVIVO, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and hVIVO wasn't on the list.
While hVIVO currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
